Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells.

Source:http://linkedlifedata.com/resource/pubmed/id/10605003

J. Immunol. 2000 Jan 1 164 1 129-35

Download in:

View as

General Info

PMID
10605003